Rankings
▼
Calendar
PRAX FY 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena
PRAX
Praxis Precision Medicines, Inc.
$7B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
-$84M
-3445.8% margin
Operating Income
-$126M
-5164.4% margin
Net Income
-$123M
-5037.9% margin
EPS (Diluted)
$-18.69
Cash Flow
Operating Cash Flow
-$111M
Free Cash Flow
-$111M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$88M
Total Liabilities
$18M
Stockholders' Equity
$70M
Cash & Equivalents
$81M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
-$84M
-$154M
+45.4%
Operating Income
-$126M
-$215M
+41.2%
Net Income
-$123M
-$214M
+42.4%
← Q4 2022
All Quarters
Q1 2023 →